NeoGenomics, Inc. Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- NeoGenomics, Inc. share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2026-06-30 was 57.66K shares, a 2968.65% increase year-over-year.
- NeoGenomics, Inc. share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2026-03-31 was 84.12K shares, a 1067.71% increase year-over-year.
- NeoGenomics, Inc. share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2025-12-31 was 26.04K shares, a 33.09% decline year-over-year.
- NeoGenomics, Inc. share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2025-09-30 was 0.00 shares, a 100.00% decline year-over-year.
- NeoGenomics, Inc. share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2025 was 35.12K shares, a 91.48% decline from fiscal 2024.
- NeoGenomics, Inc. share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2024 was 412.44K shares, a 47.75% increase from fiscal 2023.
- NeoGenomics, Inc. share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2023 was 279.15K shares, a 70.59% decline from fiscal 2022.
- NeoGenomics, Inc. share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2022 was 949.26K shares, a 30.84% decline from fiscal 2021.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period 12 month |
|---|---|---|
| 2026-06-30 | 57.66K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-28 | 167.82K shares derived: sum of 4 quarters · filed 2026-07-28 |
| 2026-03-31 | 84.12K shares 10-Q · filed 2026-04-28 | 112.04K shares derived: sum of 4 quarters · filed 2026-04-28 |
| 2025-12-31 | 26.04K shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-17 | 35.12K shares 10-K · filed 2026-02-17 |
| 2025-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-28 | 48.00K shares derived: sum of 4 quarters · filed 2026-02-17 |
| 2025-06-30 | 1.88K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2025-07-29 | 127.15K shares derived: sum of 4 quarters · filed 2026-02-17 |
| 2025-03-31 | 7.20K shares 10-Q · filed 2025-04-29 | 406.88K shares derived: sum of 4 quarters · filed 2026-02-17 |
| 2024-12-31 | 38.92K shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-17 | 412.44K shares 10-K · filed 2026-02-17 |
| 2024-09-30 | 79.15K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-05 | 429.63K shares derived: sum of 4 quarters · filed 2026-02-17 |
| 2024-06-30 | 281.61K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2024-07-30 | 438.42K shares derived: sum of 4 quarters · filed 2026-02-17 |
| 2024-03-31 | 12.76K shares 10-Q · filed 2024-04-30 | 216.88K shares derived: sum of 4 quarters · filed 2026-02-17 |
| 2023-12-31 | 56.10K shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-17 | 279.15K shares 10-K · filed 2026-02-17 |
| 2023-09-30 | 87.94K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-06 | 367.75K shares derived: sum of 4 quarters · filed 2025-02-18 |
| 2023-06-30 | 60.07K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-08 | 517.78K shares derived: sum of 4 quarters · filed 2025-02-18 |
| 2023-03-31 | 75.03K shares 10-Q · filed 2023-05-09 | 552.68K shares derived: sum of 4 quarters · filed 2025-02-18 |
| 2022-12-31 | 144.70K shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-18 | 949.26K shares 10-K · filed 2025-02-18 |
| 2022-09-30 | 237.97K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-08 | 1.25M shares derived: sum of 4 quarters · filed 2024-02-20 |
| 2022-06-30 | 94.97K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-09 | 1.33M shares derived: sum of 4 quarters · filed 2024-02-20 |
| 2022-03-31 | 471.61K shares 10-Q · filed 2022-05-09 | 1.58M shares derived: sum of 4 quarters · filed 2024-02-20 |
| 2021-12-31 | 440.61K shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-20 | 1.37M shares 10-K · filed 2024-02-20 |
| 2021-09-30 | 319.65K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-04 | 1.97M shares derived: sum of 4 quarters · filed 2023-02-24 |
| 2021-06-30 | 352.14K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-09 | 2.23M shares derived: sum of 4 quarters · filed 2023-02-24 |
| 2021-03-31 | 260.17K shares 10-Q · filed 2021-05-06 | 2.07M shares derived: sum of 4 quarters · filed 2023-02-24 |
| 2020-12-31 | 1.03M shares derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-24 | 2.31M shares 10-K · filed 2023-02-24 |
| 2020-09-30 | 584.85K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2020-10-29 | 2.15M shares derived: sum of 4 quarters · filed 2022-02-25 |
| 2020-06-30 | 187.17K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2020-07-31 | 1.85M shares derived: sum of 4 quarters · filed 2022-02-25 |
| 2020-03-31 | 504.13K shares 10-Q · filed 2020-04-29 | 2.18M shares derived: sum of 4 quarters · filed 2022-02-25 |
| 2019-12-31 | 869.58K shares derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-25 | 2.31M shares 10-K · filed 2022-02-25 |
| 2019-09-30 | 289.08K shares 10-Q · filed 2020-10-29 | 1.92M shares derived: sum of 4 quarters · filed 2021-02-25 |
| 2019-06-30 | 515.53K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-07 | 1.69M shares derived: sum of 4 quarters · filed 2021-02-25 |
| 2019-03-31 | 635.26K shares 10-Q · filed 2019-05-08 | 2.13M shares derived: sum of 4 quarters · filed 2021-02-25 |
| 2018-12-31 | 475.89K shares derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-25 | 1.57M shares 10-K · filed 2021-02-25 |
| 2018-09-30 | 63.75K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-06 | 1.16M shares derived: sum of 4 quarters · filed 2020-02-28 |
| 2018-06-30 | 958.08K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-06 | 1.27M shares derived: sum of 4 quarters · filed 2020-02-28 |
| 2018-03-31 | 72.50K shares 10-Q · filed 2018-05-08 | 427.42K shares derived: sum of 4 quarters · filed 2020-02-28 |
| 2017-12-31 | 62.25K shares derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-28 | 565.57K shares 10-K · filed 2020-02-28 |
| 2017-09-30 | 173.50K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-13 | 591.82K shares derived: sum of 4 quarters · filed 2019-02-26 |
| 2017-06-30 | 119.17K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-07 | 809.74K shares derived: sum of 4 quarters · filed 2019-02-26 |
| 2017-03-31 | 210.65K shares 10-Q · filed 2017-05-09 | 1.48M shares derived: sum of 4 quarters · filed 2019-02-26 |
| 2016-12-31 | 88.50K shares derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-26 | 2.48M shares 10-K · filed 2019-02-26 |
| 2016-09-30 | 391.42K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-07 | 2.60M shares derived: sum of 4 quarters · filed 2018-03-13 |
| 2016-06-30 | 785.30K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-05 | 2.29M shares derived: sum of 4 quarters · filed 2018-03-13 |
| 2016-03-31 | 1.22M shares 10-Q · filed 2016-05-10 | 1.64M shares derived: sum of 4 quarters · filed 2018-03-13 |
| 2015-12-31 | 202.97K shares derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-13 | 492.09K shares 10-K · filed 2018-03-13 |
| 2015-09-30 | 81.50K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-06 | |
| 2015-06-30 | 139.75K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2015-07-31 | |
| 2015-03-31 | 67.88K shares 10-Q · filed 2015-05-11 | |
| 2014-12-31 | 2.39M shares 10-K · filed 2017-03-14 | |
| 2013-12-31 | 439.00K shares 10-K · filed 2016-04-18 | |
| 2012-12-31 | 197.21K shares 10-K · filed 2015-03-03 | |
| 2011-12-31 | 382.50K shares 10-K · filed 2014-02-24 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| 20/20 Biolabs, Inc. (AIDX) | United States | $0.005B |